Nymox Pharmaceutical Corporation – NASDAQ:NYMX
Nymox Pharmaceutical stock price monthly change
Nymox Pharmaceutical stock price quarterly change
Nymox Pharmaceutical stock price yearly change
Nymox Pharmaceutical key metrics
Market Cap | 18.24M |
Enterprise value | 30.04M |
P/E | -3.96 |
EV/Sales | N/A |
EV/EBITDA | -3.83 |
Price/Sales | N/A |
Price/Book | 42.06 |
PEG ratio | -0.63 |
EPS | -0.09 |
Revenue | N/A |
EBITDA | -1.92M |
Income | -8.48M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNymox Pharmaceutical stock price history
Nymox Pharmaceutical stock forecast
Nymox Pharmaceutical financial statements
| Sep 2022 | 0 | -1.50M | |
|---|---|---|---|
| Dec 2022 | 0 | -4.48M | |
| Mar 2023 | 0 | -1.38M | |
| Jun 2023 | 0 | -1.11M |
| 2022-08-15 | 0.01 | 0.01 |
|---|---|---|
| 2022-11-14 | -0.02 | -0.02 |
| Sep 2022 | 3141000 | 2.36M | 75.39% |
|---|---|---|---|
| Dec 2022 | 1625000 | 2.10M | 129.66% |
| Mar 2023 | 575000 | 2.37M | 412.87% |
| Jun 2023 | 271000 | 3.14M | 1161.62% |
| Sep 2022 | -1.30M | 0 | -60K |
|---|---|---|---|
| Dec 2022 | -1.24M | 0 | -52K |
| Mar 2023 | -988K | -3K | -61K |
| Jun 2023 | -909K | 0 | 690K |
Nymox Pharmaceutical alternative data
| Aug 2023 | 3 |
|---|---|
| Sep 2023 | 3 |
| Oct 2023 | 3 |
| Nov 2023 | 3 |
| Dec 2023 | 3 |
| Jan 2024 | 3 |
| Feb 2024 | 3 |
| Mar 2024 | 3 |
| Apr 2024 | 3 |
| May 2024 | 3 |
| Jun 2024 | 3 |
| Jul 2024 | 3 |
Nymox Pharmaceutical other data
| Period | Buy | Sel |
|---|---|---|
| May 2022 | 1151515 | 0 |
| Apr 2023 | 40000 | 0 |
Monday, 23 October 2023 | ||
| The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting | businesswire.com | |
Thursday, 6 July 2023 | ||
| Why Is Nymox Pharmaceutical (NYMX) Stock Down 18% Today? | InvestorPlace | |
Monday, 23 May 2022 | ||
| Why Nymox Pharma Shares Sinking to 52-Week Low? | Benzinga | |
Monday, 11 October 2021 | ||
| NYMOX Provides Current Update | GlobeNewsWire | |
Friday, 10 September 2021 | ||
| NYMOX Provides Shareholder Update | GlobeNewsWire | |
Wednesday, 8 September 2021 | ||
| 4 Biotech Penny Stocks To Watch After EFTR Stock Jumps 351% | PennyStocks |
-
When is Nymox Pharmaceutical's next earnings date?
Unfortunately, Nymox Pharmaceutical's (NYMX) next earnings date is currently unknown.
-
Does Nymox Pharmaceutical pay dividends?
No, Nymox Pharmaceutical does not pay dividends.
-
How much money does Nymox Pharmaceutical make?
Nymox Pharmaceutical has a market capitalization of 18.24M. Nymox Pharmaceutical made a loss 6.57M US dollars in net income (profit) last year or -$0.02 on an earnings per share basis.
-
What is Nymox Pharmaceutical's stock symbol?
Nymox Pharmaceutical Corporation is traded on the NASDAQ under the ticker symbol "NYMX".
-
What is Nymox Pharmaceutical's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Nymox Pharmaceutical?
Shares of Nymox Pharmaceutical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Nymox Pharmaceutical's key executives?
Nymox Pharmaceutical's management team includes the following people:
- Mr. Erik Danielsen Chief Financial Officer & Controller(age: 62, pay: $535,000)
- Mr. Randall J. Lanham Esq., J.D. Gen. Counsel, Sec., Chief Operating Officer & Director(age: 61, pay: $324,770)
-
How many employees does Nymox Pharmaceutical have?
As Jul 2024, Nymox Pharmaceutical employs 3 workers.
-
When Nymox Pharmaceutical went public?
Nymox Pharmaceutical Corporation is publicly traded company for more then 27 years since IPO on 26 Nov 1997.
-
What is Nymox Pharmaceutical's official website?
The official website for Nymox Pharmaceutical is nymox.com.
-
How can i contact Nymox Pharmaceutical?
Nymox Pharmaceutical can be reached via phone at +1 800 936 9669.
Nymox Pharmaceutical company profile:
Nymox Pharmaceutical Corporation
nymox.comNASDAQ
3
Biotechnology
Healthcare
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.
Nassau,
CIK: 0001018735
ISIN: BSP733981026
CUSIP: P73398102
